Susquehanna International »

Dianthus Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.2M 206k 30.00

More positions owned by Susquehanna International

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Advanced Micro Devices (AMD)
Netflix (NFLX)
Super Micro Computer (SMCI)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Susquehanna International

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics